NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ICF International, Inc. ICFI, Invitae Corporation NVTA, Encore Wire Corporation WIRE, Alexandria Real Estate Equities, Inc. ARE, Syndax Pharmaceuticals, Inc. SNDX, and Vical Incorporated VICL, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
ICFI DOWNLOAD: http://Fundamental-Markets.com/register/?so=ICFI
NVTA DOWNLOAD: http://Fundamental-Markets.com/register/?so=NVTA
WIRE DOWNLOAD: http://Fundamental-Markets.com/register/?so=WIRE
ARE DOWNLOAD: http://Fundamental-Markets.com/register/?so=ARE
SNDX DOWNLOAD: http://Fundamental-Markets.com/register/?so=SNDX
VICL DOWNLOAD: http://Fundamental-Markets.com/register/?so=VICL
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine ICF International, Inc. ICFI, Invitae Corporation NVTA, Encore Wire Corporation WIRE, Alexandria Real Estate Equities, Inc. ARE, Syndax Pharmaceuticals, Inc. SNDX, and Vical Incorporated VICL on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 16th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
ICF INTERNATIONAL, INC. (ICFI) REPORT OVERVIEW
ICF International's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, ICF International reported revenue of $321.17MM vs $289.56MM (up 10.92%) and basic earnings per share $1.44 vs $0.66 (up 118.18%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, ICF International reported revenue of $1,229.16MM vs $1,185.10MM (up 3.72%) and basic earnings per share $3.35 vs $2.45 (up 36.73%). ICF International is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.69. The estimated EPS forecast for the next fiscal year is $4.04 and is expected to report on February 26th, 2019.
To read the full ICF International, Inc. (ICFI) report, download it here: http://Fundamental-Markets.com/register/?so=ICFI
-----------------------------------------
INVITAE CORPORATION (NVTA) REPORT OVERVIEW
Invitae's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Invitae reported revenue of $25.40MM vs $9.24MM (up 175.00%) and basic earnings per share -$0.78 vs -$0.68. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Invitae reported revenue of $68.22MM vs $25.05MM (up 172.36%) and basic earnings per share -$2.65 vs -$3.02. Invitae is expected to report earnings on May 14th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.64. The estimated EPS forecast for the next fiscal year is -$1.61 and is expected to report on February 11th, 2019.
To read the full Invitae Corporation (NVTA) report, download it here: http://Fundamental-Markets.com/register/?so=NVTA
-----------------------------------------
ENCORE WIRE CORPORATION (WIRE) REPORT OVERVIEW
Encore Wire's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Encore Wire reported revenue of $301.29MM vs $239.25MM (up 25.93%) and basic earnings per share $1.37 vs $0.54 (up 153.70%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Encore Wire reported revenue of $1,164.25MM vs $940.79MM (up 23.75%) and basic earnings per share $3.23 vs $1.63 (up 98.16%). Encore Wire is expected to report earnings on May 1st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.65. The estimated EPS forecast for the next fiscal year is $3.25 and is expected to report on February 19th, 2019.
To read the full Encore Wire Corporation (WIRE) report, download it here: http://Fundamental-Markets.com/register/?so=WIRE
-----------------------------------------
ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) REPORT OVERVIEW
Alexandria Real Estate Equities' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Alexandria Real Estate Equities reported revenue of $298.79MM vs $249.16MM (up 19.92%) and basic earnings per share $0.40 vs -$0.29. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Alexandria Real Estate Equities reported revenue of $1,128.10MM vs $921.71MM (up 22.39%) and basic earnings per share $1.59 vs -$1.99. Alexandria Real Estate Equities is expected to report earnings on April 30th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $1.48. The estimated EPS forecast for the next fiscal year is $6.95 and is expected to report on February 4th, 2019.
To read the full Alexandria Real Estate Equities, Inc. (ARE) report, download it here: http://Fundamental-Markets.com/register/?so=ARE
-----------------------------------------
SYNDAX PHARMACEUTICALS, INC. (SNDX) REPORT OVERVIEW
Syndax Pharmaceuticals' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Syndax Pharmaceuticals reported revenue of $1.19MM vs $0.31MM (up 291.15%) and basic earnings per share -$0.81 vs $0.94. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Syndax Pharmaceuticals reported revenue of $2.11MM vs $1.22MM (up 72.79%) and basic earnings per share -$2.90 vs -$3.22. Syndax Pharmaceuticals is expected to report earnings on May 14th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.71. The estimated EPS forecast for the next fiscal year is -$3.50 and is expected to report on March 4th, 2019.
To read the full Syndax Pharmaceuticals, Inc. (SNDX) report, download it here: http://Fundamental-Markets.com/register/?so=SNDX
-----------------------------------------
VICAL INCORPORATED (VICL) REPORT OVERVIEW
Vical's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Vical reported revenue of $3.95MM vs $3.16MM (up 24.98%) and basic earnings per share -$0.19 vs -$0.26. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Vical reported revenue of $13.82MM vs $14.53MM (down 4.90%) and basic earnings per share -$1.01 vs -$0.90. Vical is expected to report earnings on May 21st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.25.
To read the full Vical Incorporated (VICL) report, download it here: http://Fundamental-Markets.com/register/?so=VICL
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
